Table 2.
Duration in days for respective respiratory support across the birth years
| Duration of days on Respiratory support modalities | Total (n = 316) |
2016 (n = 66) |
2017 (n = 63) |
2018 (n = 61) |
2019 (n = 85) |
2020 (n = 41) |
P value |
|---|---|---|---|---|---|---|---|
| MV |
12 [5–28] |
12 [5–28] | 14 [5–28] | 11 [4–28] | 12 [5–25] | 12 [6–25] | 0.68 |
| CPAP |
7 [3–12] |
7 [3.5–16.5] | 6 [3–9] | 5.5 [2.5–10] | 6 [3–13.5] | 10.5 [6–12] | 0.79 |
| HHHFNC |
13 [7–22] |
10 [4–23] | 18 [8–23] | 16 [9–22] | 12.5 [6–21.5] | 12 [8–22] | < 0.01 |
| Low-flow nasal cannula |
12 [5–21] |
17 [9–26] | 10 [4–19] | 14 [6–21] | 8 [3–18] | 8.5 [5–19] | < 0.01 |
Data are presented as medians (interquartile range [IQR] ). MV: mechanical ventilation, CPAP: continuous positive airway pressure, HHHFNC: heated humidified high-flow nasal cannula